http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102275326-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2014-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102275326-B1
titleOfInvention Bisulfate of janus kinase (jak) inhibitor and preparation method therefor
abstract The present invention relates to bisulfates of Janus kinase (JAK) inhibitors and methods for their preparation. More specifically, the present invention relates to (3aR,5s,6aS)-N-(3-methoxy-1,2,4-thiadiazole-5-group)-5-(methyl(7H- pyrrolo[2,3-d]pyrimidin-4-yl)amino)hexahydrocyclopenta[c]pyrrole-2(1H)-formamide bisulfate, a process for its preparation, and uses thereof. The bisulfate represented by the following formula (I) can be well used as a Janus kinase (JAK) inhibitor in clinical studies, and thus can be well used for the treatment of rheumatism or rheumatoid arthritis. [Formula I]
priorityDate 2013-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006523190-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0200661-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3330246
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9926791
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20753133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419650968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586486
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID314179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415935728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457569339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6730163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457501988
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6612803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476643

Total number of triples: 53.